Correlation Between Akums Drugs and Spandana Sphoorty

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akums Drugs and Spandana Sphoorty at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akums Drugs and Spandana Sphoorty into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akums Drugs and and Spandana Sphoorty Financial, you can compare the effects of market volatilities on Akums Drugs and Spandana Sphoorty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Spandana Sphoorty. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Spandana Sphoorty.

Diversification Opportunities for Akums Drugs and Spandana Sphoorty

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Akums and Spandana is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Spandana Sphoorty Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spandana Sphoorty and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Spandana Sphoorty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spandana Sphoorty has no effect on the direction of Akums Drugs i.e., Akums Drugs and Spandana Sphoorty go up and down completely randomly.

Pair Corralation between Akums Drugs and Spandana Sphoorty

Assuming the 90 days trading horizon Akums Drugs is expected to generate 11.89 times less return on investment than Spandana Sphoorty. But when comparing it to its historical volatility, Akums Drugs and is 2.14 times less risky than Spandana Sphoorty. It trades about 0.03 of its potential returns per unit of risk. Spandana Sphoorty Financial is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  38,475  in Spandana Sphoorty Financial on October 12, 2024 and sell it today you would earn a total of  6,610  from holding Spandana Sphoorty Financial or generate 17.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Akums Drugs and  vs.  Spandana Sphoorty Financial

 Performance 
       Timeline  
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Spandana Sphoorty 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spandana Sphoorty Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Akums Drugs and Spandana Sphoorty Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akums Drugs and Spandana Sphoorty

The main advantage of trading using opposite Akums Drugs and Spandana Sphoorty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Spandana Sphoorty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spandana Sphoorty will offset losses from the drop in Spandana Sphoorty's long position.
The idea behind Akums Drugs and and Spandana Sphoorty Financial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity